These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 8333254
1. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Jenner P. Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254 [Abstract] [Full Text] [Related]
4. Oxidative mechanisms in nigral cell death in Parkinson's disease. Jenner P. Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715 [Abstract] [Full Text] [Related]
5. Clues to the mechanism underlying dopamine cell death in Parkinson's disease. Jenner P. J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):22-8. PubMed ID: 2666576 [Abstract] [Full Text] [Related]
6. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH. Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590 [Abstract] [Full Text] [Related]
7. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH. J Neurol Sci; 1998 Jun 11; 158(1):24-9. PubMed ID: 9667773 [Abstract] [Full Text] [Related]
8. The possible role of iron in the etiopathology of Parkinson's disease. Youdim MB, Ben-Shachar D, Riederer P. Mov Disord; 1993 Jun 11; 8(1):1-12. PubMed ID: 8419792 [Abstract] [Full Text] [Related]
9. Does oxidative stress participate in nerve cell death in Parkinson's disease? Hirsch EC. Eur Neurol; 1993 Jun 11; 33 Suppl 1():52-9. PubMed ID: 8375433 [Abstract] [Full Text] [Related]
10. Pathogenesis and animal studies of Parkinson's disease. Oertel WH, Kupsch A. Curr Opin Neurol Neurosurg; 1993 Jun 11; 6(3):323-32. PubMed ID: 8507901 [Abstract] [Full Text] [Related]
11. Oxidative stress and Parkinson's disease. Owen AD, Schapira AH, Jenner P, Marsden CD. Ann N Y Acad Sci; 1996 Jun 15; 786():217-23. PubMed ID: 8687021 [Abstract] [Full Text] [Related]
12. Iron metabolism and Parkinson's disease. Hirsch EC, Faucheux BA. Mov Disord; 1998 Jun 15; 13 Suppl 1():39-45. PubMed ID: 9613717 [Abstract] [Full Text] [Related]
13. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease? Andersen JK. Novartis Found Symp; 2001 Jun 15; 235():11-20; discussion 20-5. PubMed ID: 11280021 [Abstract] [Full Text] [Related]
14. Presymptomatic detection of Parkinson's disease. Jenner P. J Neural Transm Suppl; 1993 Jun 15; 40():23-36. PubMed ID: 8294898 [Abstract] [Full Text] [Related]
15. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD. J Neural Transm (Vienna); 1997 Jun 15; 104(6-7):661-77. PubMed ID: 9444566 [Abstract] [Full Text] [Related]
16. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. Ann Neurol; 1994 Sep 15; 36(3):348-55. PubMed ID: 8080242 [Abstract] [Full Text] [Related]
17. Oxidative stress as a cause of Parkinson's disease. Jenner P. Acta Neurol Scand Suppl; 1991 Sep 15; 136():6-15. PubMed ID: 1801537 [Abstract] [Full Text] [Related]
18. Mitochondrial energy crisis in Parkinson's disease. Mizuno Y, Ikebe S, Hattori N, Kondo T, Tanaka M, Ozawa T. Adv Neurol; 1993 Sep 15; 60():282-7. PubMed ID: 8420144 [No Abstract] [Full Text] [Related]